Sign inJoin waitlistJoin the waitlist

Ching-Wei Tzeng

Program Director · University of Texas M D Anderson Cancer Center

Credentials: · · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present
Hepatobiliary Surgery and HPB Fellowship · University of Texas M D Anderson Cancer Center
Present
Hepatobiliary Surgery and HPB Fellowship Program Director Division · University of Texas M D Anderson Cancer Center
Present

University of Texas M D Anderson Cancer Center
2012–2013
Complex General Surgical Oncology
University of Texas M D Anderson Cancer Center
2010–2012
Surgery
University of Alabama Hospital
2003–2010
National Institutes of Health
2005–2007
University of Alabama at Birmingham Marnix E. Heersink School of Medicine
1999–2003

Research

Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Cell · 2019 · 1,281 citations
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
The Lancet. Gastroenterology & hepatology · 2022 · 241 citations
Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases
Clinical Cancer Research · 2019 · 143 citations

Jean-Nicolas Vauthey
136 papers
Matthew Katz
127 papers
Jeffrey Lee
100 papers
Timothy Newhook
97 papers · 14 as a fellow
Yun Chun
87 papers
Michael Kim
86 papers
Naruhiko Ikoma
82 papers · 1 as a fellow
Hop Cao
70 papers
Jessica Maxwell
58 papers · 1 as a fellow
Thomas Aloia
51 papers
Rebecca Snyder
43 papers · 1 as a fellow
Eugene Koay
30 papers

Clinical trials

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2024–2026
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
Principal investigator · Recruiting · Phase 1
M.D. Anderson Cancer Center
2022–2028
Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2019–2025
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Site PI · Recruiting · Phase 1
PanTher Therapeutics
2025–2028